🇺🇸 FDA
Pipeline program

Vabysmo 120 mg/mL solution for injection in pre-filled syringe

FARIDUO

Approved small_molecule active

Quick answer

Vabysmo 120 mg/mL solution for injection in pre-filled syringe for SUBRETINAL HYPERREFLECTIVE MATERIAL is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
SUBRETINAL HYPERREFLECTIVE MATERIAL
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials